| 1 | Assessing Quality and Adherence to PI-RADSv2.1 Minimum Technical Standards of Prostate MRI in NRG-GU005. (Alley S, Tonneau M, Olivié D, Tempany-Afdhal CM, Choyke PL, Turkbey IB, van der Heide UA, Ellis RJ, Kadoury S, Boike TP, Pennington JD, Frazier A, Lawton CAF, Leong N, Mihai AM, Morgan SC, Solanki AA, Michalski JM, Feng FY, Sandler HM, Menard C) J Magn Reson Imaging 2026 Feb;63(2):464-474 1 Citation |
| 1 | Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence. (Ku AT, Shankavaram U, Trostel SY, Zhang H, Kartal S, Sater HA, Harmon SA, Carrabba NV, Liu Y, Ryu H, Proudfoot JA, Hong BH, Wood BJ, Pinto PA, Choyke PL, Roach M, Sandler HM, Pugh SL, Zeitzer KL, Mendez LC, Kapadia NS, Hall WA, Desai AB, Stoyanova RS, Pollack A, Davicioni E, Chua MLK, Turkbey B, Sowalsky AG, Citrin DE) Clin Cancer Res 2025 Dec 15;31(24):5211-5224 2 Citations |
| 1 | The Role of Dynamic Contrast Enhanced Magnetic Resonance Imaging in Evaluating Prostate Adenocarcinoma: A Partially-Blinded Retrospective Study of a Prostatectomy Patient Cohort With Whole Gland Histopathology Correlation and Application of PI-RADS or TNM Staging. (Sridhar S, Abouelfetouh Z, Codreanu I, Gupta N, Zhang S, Efstathiou E, Karolyi DK, Shen SS, LaViolette PS, Miles B, Martin DR) Prostate 2025 Apr;85(5):413-423 3 Citations |
| 1 | Correlation of Prostate High-Resolution Microultrasound With Multiparametric Magnetic Resonance Imaging. (Pickersgill NA, Alkazemi MH, Ostergar A, Joseph K, Vetter JM, Barashi NS, Kim EH, Andriole GL, Sivaraman A) Urology 2025 Mar;197:33-39 2 Citations |
| 1 | Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials. (Patel KR, Nguyen PL, Proudfoot JA, Liu Y, Pra AD, Spratt DE, Pollack A, Sandler HM, Efstathiou JA, Lawton C, Simko JP, Rosenthal SA, Zeitzer KL, Mendez LC, Hartford AC, Hall WA, Desai AB, Pugh SL, Davicioni E, Tran PT, Feng FY) Eur Urol Oncol 2026 Apr;9(2):413-421 2 Citations |
| 3 | Morphologic features of prostate cancer-encased native vessels: An image analysis study. (Fernandez Gonzalez De La Vega C, Duenweg S, Jain P, Rubenstein SI, Bobholz S, Barrett MJ, LaViolette PS, Iczkowski KA) Pathol Res Pract 2024 Apr;256:155239 2 Citations |
| 1 | Urinary Symptoms Change and Quality of Life After Robotic Radical Prostatectomy: A Secondary Analysis of a Randomized Controlled Trial. (Tourinho-Barbosa R, Sanchez-Salas R, Sivaraman A, Borges RC, Candela L, Batista LT, Cathala N, Mombet A, Marra G, Sanchez LR, Boumezrag CB, Lanz C, Macek P, Cathelineau X, Korkes F) Urology 2024 Mar;185:73-79 4 Citations |
| 1 | The impact of margin reduction on radiation dose distribution of ultra-hypofractionated prostate radiotherapy utilizing a 1.5-T MR-Linac. (Onal C, Efe E, Bozca R, Yavas C, Yavas G, Arslan G) J Appl Clin Med Phys 2024 Jan;25(1):e14179 8 Citations |
| 3 | Quantitative Histomorphometric Features of Prostate Cancer Predict Patients Who Biochemically Recur Following Prostatectomy. (Duenweg SR, Brehler M, Lowman AK, Bobholz SA, Kyereme F, Winiarz A, Nath B, Iczkowski KA, Jacobsohn KM, LaViolette PS) Lab Invest 2023 Dec;103(12):100269 4 Citations |
| 1 | Prostate Adenocarcinoma Metastasis to the Rectal Submucosa and Mesorectal Lymph Node on 18 F-PSMA PET/CT. (Segal E, Dababo N, Bhalla D, Bucklan D) Clin Nucl Med 2023 Oct 01;48(10):e506-e508 3 Citations |
| 1 | Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate. (Roy S, Romero T, Michalski JM, Feng FY, Efstathiou JA, Lawton CAF, Bolla M, Maingon P, de Reijke T, Joseph D, Ong WL, Sydes MR, Dearnaley DP, Tree AC, Carrier N, Nabid A, Souhami L, Incrocci L, Heemsbergen WD, Pos FJ, Zapatero A, Guerrero A, Alvarez A, San-Segundo CG, Maldonado X, Reiter RE, Rettig MB, Nickols NG, Steinberg ML, Valle LF, Ma TM, Farrell MJ, Neilsen BK, Juarez JE, Deng J, Vangala S, Avril N, Jia AY, Zaorsky NG, Sun Y, Spratt D, Kishan AU, Meta-Analysis of Randomized Trials in Cancer of the Prostate (MARCAP) Consortium Investigators) J Clin Oncol 2023 Nov 10;41(32):5005-5014 23 Citations |
| 3 | Comparison of a machine and deep learning model for automated tumor annotation on digitized whole slide prostate cancer histology. (Duenweg SR, Brehler M, Bobholz SA, Lowman AK, Winiarz A, Kyereme F, Nencka A, Iczkowski KA, LaViolette PS) PLoS One 2023;18(3):e0278084 8 Citations |
| 2 | Confirming and Refining Our Existing Postoperative Treatment Strategies Through the Use of Novel Prostate-Specific Positron Emission Tomography (PET) Imaging. (Hall WA, Lawton CAF) Int J Radiat Oncol Biol Phys 2023 Jan 01;115(1):118-119 |
| 1 | Dynamic nucleosome landscape elicits a noncanonical GATA2 pioneer model. (Li T, Liu Q, Chen Z, Fang K, Huang F, Fu X, Wang Q, Jin VX) Nat Commun 2022 Jun 07;13(1):3145 5 Citations |
| 1 | AAPM task group report 303 endorsed by the ABS: MRI implementation in HDR brachytherapy-Considerations from simulation to treatment. (Prisciandaro J, Zoberi JE, Cohen G, Kim Y, Johnson P, Paulson E, Song W, Hwang KP, Erickson B, Beriwal S, Kirisits C, Mourtada F) Med Phys 2022 Aug;49(8):e983-e1023 24 Citations |
| 3 | Diffusion Restriction Comparison between Gleason 4 Fused Glands and Cribriform Glands within Patient Using Whole-Mount Prostate Pathology as Ground Truth. (Duenweg SR, Fang X, Bobholz SA, Lowman AK, Brehler M, Kyereme F, Iczkowski KA, Jacobsohn KM, Banerjee A, LaViolette PS) Tomography 2022 Mar 02;8(2):635-643 4 Citations |
| 1 | Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer. (Kerns SL, Amidon Morlang A, Lee SM, Peterson DR, Marples B, Zhang H, Bylund K, Rosenzweig D, Hall W, De Ruyck K, Rosenstein BS, Stock RG, Gómez-Caamaño A, Vega A, Sosa-Fajardo P, Taboada-Valladares B, Aguado-Barrera ME, Parker C, Veldeman L, Fonteyne V, Bultijnck R, Talbot CJ, Symonds RP, Johnson K, Rattay T, Webb A, Lambrecht M, de Ruysscher D, Vanneste B, Choudhury A, Elliott RM, Sperk E, Herskind C, Veldwijk MR, Rancati T, Avuzzi B, Valdagni R, Azria D, Farcy Jacquet MP, Chang-Claude J, Seibold P, West C, Janelsins M, Chen Y, Messing E, Morrow G, REQUITE Consortium) Radiother Oncol 2022 Mar;168:75-82 18 Citations |
| 1 | Analysis of CDK12 alterations in a pan-cancer database. (Pan E, Cabal A, Javier-DesLoges J, Patel D, Panian J, Lee S, Shaya J, Nonato T, Xu X, Stewart T, Rose B, Shabaik A, Cohen E, Kurzrock R, Tamayo P, McKay RR) Cancer Med 2022 Feb;11(3):753-763 8 Citations |
| 1 | Histological validation of prostate tissue composition measurement using hybrid multi-dimensional MRI: agreement with pathologists' measures. (Chatterjee A, Antic T, Gallan AJ, Paner GP, Lin LI, Karczmar GS, Oto A) Abdom Radiol (NY) 2022 Feb;47(2):801-813 12 Citations |
| 2 | The prognostic value of digital rectal exam for the existence of advanced pathologic features after prostatectomy. (Prebay ZJ, Medairos R, Doolittle J, Langenstroer P, Jacobsohn K, See WA, Johnson SC) Prostate 2021 Oct;81(14):1064-1070 12 Citations |
| 1 | Comparative Outcomes of Salvage Retzius-Sparing versus Standard Robotic Prostatectomy: An International, Multi-Surgeon Series. (Kowalczyk KJ, Madi RH, Eden CG, Sooriakumaran P, Fransis K, Raskin Y, Joniau S, Johnson S, Jacobsohn K, Galfano A, Bocciardi AM, Hwang J, Kim IY, Hu JC) J Urol 2021 Nov;206(5):1184-1191 27 Citations |
| 1 | Cluster analysis of men undergoing surgery for BPH/LUTS reveals prominent roles of both bladder outlet obstruction and diminished bladder contractility. (Schneider AJ, Grimes M, Lyon W, Kemper A, Wang S, Bushman W) PLoS One 2021;16(5):e0251721 14 Citations |
| 6 | Long-Term Outcomes of Dose-Escalated Pelvic Lymph Node Intensity-Modulated Radiation Therapy (IMRT) With a Simultaneous Hypofractionated Boost to the Prostate for Very High-Risk Adenocarcinoma of the Prostate: A Prospective Phase II Clinical Trial. (Hall WA, Bedi M, Kilari D, Bylow KA, Burfeind J, Johnstone C, Siker M, Currey A, See WA, Nelson A, Johnson S, Straza M, Lawton CAF) Pract Radiat Oncol 2021;11(6):527-533 6 Citations |
| 1 | Comparative influence of cribriform growth and percent Gleason 4 in prostatic biopsies with Gleason 3+4 cancer. (Czaja RC, Tarima S, Wu R, Palagnmonthip W, Iczkowski KA) Ann Diagn Pathol 2021 Jun;52:151725 4 Citations |
| 1 | Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5-SN38 Antibody-drug Conjugate in Neuroendocrine Prostate Cancer. (DeLucia DC, Cardillo TM, Ang L, Labrecque MP, Zhang A, Hopkins JE, De Sarkar N, Coleman I, da Costa RMG, Corey E, True LD, Haffner MC, Schweizer MT, Morrissey C, Nelson PS, Lee JK) Clin Cancer Res 2021 Feb 01;27(3):759-774 76 Citations |
| 3 | Corpora amylacea in benign prostatic acini are associated with concurrent, predominantly low-grade cancer. (Palangmonthip W, Wu R, Tarima S, Bobholz SA, LaViolette PS, Gallan AJ, Iczkowski KA) Prostate 2020 Jun;80(9):687-697 8 Citations |
| 1 | Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902. (Hamstra DA, Pugh SL, Lepor H, Rosenthal SA, Pienta KJ, Gomella L, Peters C, D'Souza DP, Zeitzer KL, Jones CU, Hall WA, Horwitz E, Pisansky TM, Souhami L, Hartford AC, Dominello M, Feng F, Sandler HM) Radiother Oncol 2019 Dec;141:137-143 12 Citations |
| 3 | Digital Rectal Examination Remains a Key Prognostic Tool for Prostate Cancer: A National Cancer Database Review. (Borkenhagen JF, Eastwood D, Kilari D, See WA, Van Wickle JD, Lawton CA, Hall WA) J Natl Compr Canc Netw 2019 Jul 01;17(7):829-837 15 Citations |
| 1 | Loss of PTEN Accelerates NKX3.1 Degradation to Promote Prostate Cancer Progression. (Bowen C, Ostrowski MC, Leone G, Gelmann EP) Cancer Res 2019 Aug 15;79(16):4124-4134 31 Citations |
| 1 | Comprehensive Evaluation of Focal Therapy Complications in Prostate Cancer: A Standardized Methodology. (Bakavicius A, Sanchez-Salas R, Muttin F, Sivaraman A, Dell'Oglio P, Barret E, Rozet F, Mombet A, Prapotnich D, Cathala N, Cathelineau X) J Endourol 2019 Jul;33(7):509-515 25 Citations |
| 1 | Immediate versus delayed prostatectomy and the fate of patients who progress to a higher risk disease on active surveillance. (Mallya A, Senguttuvan-Karthikeyan V, Sivaraman A, Barret E, Galiano M, Cathala N, Mombet A, Prapotnich D, Sanchez-Salas R, Cathelineau X) Actas Urol Esp (Engl Ed) 2019;43(6):324-330 1 Citation |
| 1 | ERG oncoprotein expression in prostatic acinar adenocarcinoma; clinicopathologic significance. (Hashmi AA, Khan EY, Irfan M, Ali R, Asif H, Naeem M, Nisar L, Faridi N, Khan A, Edhi MM) BMC Res Notes 2019 Jan 18;12(1):35 8 Citations |
| 4 | Radio-pathomic Maps of Epithelium and Lumen Density Predict the Location of High-Grade Prostate Cancer. (McGarry SD, Hurrell SL, Iczkowski KA, Hall W, Kaczmarowski AL, Banerjee A, Keuter T, Jacobsohn K, Bukowy JD, Nevalainen MT, Hohenwalter MD, See WA, LaViolette PS) Int J Radiat Oncol Biol Phys 2018 Aug 01;101(5):1179-1187 53 Citations |
| 1 | Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer. (Wu YM, Cieślik M, Lonigro RJ, Vats P, Reimers MA, Cao X, Ning Y, Wang L, Kunju LP, de Sarkar N, Heath EI, Chou J, Feng FY, Nelson PS, de Bono JS, Zou W, Montgomery B, Alva A, PCF/SU2C International Prostate Cancer Dream Team, Robinson DR, Chinnaiyan AM) Cell 2018 Jun 14;173(7):1770-1782.e14 506 Citations |
| 1 | Prostate Cancer: Improving the Flow of Research. (Lawton CAF) Radiology 2018 Apr;287(1):5-9 3 Citations |
| 1 | Can pelvic node dissection at radical prostatectomy influence the nodal recurrence at salvage lymphadenectomy for prostate cancer? (Sivaraman A, Benfante N, Touijer K, Coleman J, Scardino P, Laudone V, Eastham J) Investig Clin Urol 2018 Mar;59(2):83-90 10 Citations |
| 1 | Diagnosis of Prostate Cancer with Noninvasive Estimation of Prostate Tissue Composition by Using Hybrid Multidimensional MR Imaging: A Feasibility Study. (Chatterjee A, Bourne RM, Wang S, Devaraj A, Gallan AJ, Antic T, Karczmar GS, Oto A) Radiology 2018 Jun;287(3):864-873 102 Citations |
| 2 | Biomarkers of Outcome in Patients With Localized Prostate Cancer Treated With Radiotherapy. (Hall WA, Lawton CA, Jani AB, Pollack A, Feng FY) Semin Radiat Oncol 2017 Jan;27(1):11-20 12 Citations |
| 1 | Higher number of transrectal ultrasound guided prostate biopsy cores is associated with higher blood loss and perioperative complications in robot assisted radical prostatectomy. (Carneiro A, Sivaraman A, Sanchez-Salas R, Nunes-Silva I, Baghdadi M, Srougi V, di Trapani E, Uriburu Pizzaro F, Doizi S, Barret E, Rozet F, Galiano M, Cathelineau X) Actas Urol Esp 2017 Apr;41(3):155-161 10 Citations |
| 1 | Clinical performance of transperineal template guided mapping biopsy for therapeutic decision making in low risk prostate cancer. (Ahallal Y, Sanchez-Salas R, Sivaraman A, Barret E, Secin FP, Validire P, Rozet F, Galiano M, Cathelineau X) Actas Urol Esp 2016 Dec;40(10):615-620 3 Citations |
| 1 | Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01. (Mak RH, Hunt D, Efstathiou JA, Heney NM, Jones CU, Lukka HR, Bahary JP, Patel M, Balogh A, Nabid A, Leibenhaut MH, Hamstra DA, Roof KS, Jeffrey Lee R, Gore EM, Sandler HM, Shipley WU) Urol Oncol 2016 Oct;34(10):430.e1-7 19 Citations |
| 1 | Evolution of prostate biopsy techniques. Looking back on a meaningful journey. (Sivaraman A, Sanchez-Salas R, Castro-Marin M, Barret E, Guillot-Tantay C, Prapotnich D, Cathelineau X) Actas Urol Esp 2016 Oct;40(8):492-8 9 Citations |
| 1 | Older patients with low Charlson score and high-risk prostate cancer benefit from radical prostatectomy. (Sivaraman A, Ordaz Jurado G, Cathelineau X, Barret E, Dell'Oglio P, Joniau S, Bianchi M, Briganti A, Spahn M, Bastian P, Chun J, Chlosta P, Gontero P, Graefen M, Jeffrey Karnes R, Marchioro G, Tombal B, Tosco L, van der Poel HH, Sanchez-Salas R) World J Urol 2016 Oct;34(10):1367-72 15 Citations |
| 2 | Toward Quantitative Whole Organ Thermoacoustics With a Clinical Array Plus One Very Low-Frequency Channel Applied to Prostate Cancer Imaging. (Patch SK, Hull D, See WA, Hanson GW) IEEE Trans Ultrason Ferroelectr Freq Control 2016 Feb;63(2):245-55 47 Citations |
| 1 | Re: can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature. (Sivaraman A, Sanchez-Salas R) Eur Urol 2015 Oct;68(4):738 21 Citations |
| 1 | DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence. (Horning AM, Awe JA, Wang CM, Liu J, Lai Z, Wang VY, Jadhav RR, Louie AD, Lin CL, Kroczak T, Chen Y, Jin VX, Abboud-Werner SL, Leach RJ, Hernandez J, Thompson IM, Saranchuk J, Drachenberg D, Chen CL, Mai S, Huang TH) Prostate 2015 Nov;75(15):1790-801 24 Citations |
| 1 | Focal High-intensity Focused Ultrasound Targeted Hemiablation for Unilateral Prostate Cancer: A Prospective Evaluation of Oncologic and Functional Outcomes. (Feijoo ER, Sivaraman A, Barret E, Sanchez-Salas R, Galiano M, Rozet F, Prapotnich D, Cathala N, Mombet A, Cathelineau X) Eur Urol 2016 Feb;69(2):214-20 139 Citations |
| 1 | Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408. (Krauss DJ, Hu C, Bahary JP, Souhami L, Gore EM, Chafe SM, Leibenhaut MH, Narayan S, Torres-Roca J, Michalski J, Zeitzer KL, Donavanik V, Sandler H, McGowan DG, Jones CU, Shipley WU) Int J Radiat Oncol Biol Phys 2015 Jul 15;92(4):863-73 29 Citations |
| 1 | Clinical utility of transperineal template-guided mapping biopsy of the prostate after negative magnetic resonance imaging-guided transrectal biopsy. (Sivaraman A, Sanchez-Salas R, Ahmed HU, Barret E, Cathala N, Mombet A, Uriburu Pizarro F, Carneiro A, Doizi S, Galiano M, Rozet F, Prapotnich D, Cathelineau X) Urol Oncol 2015 Jul;33(7):329.e7-11 10 Citations |
| 2 | Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer. (Xia S, Kohli M, Du M, Dittmar RL, Lee A, Nandy D, Yuan T, Guo Y, Wang Y, Tschannen MR, Worthey E, Jacob H, See W, Kilari D, Wang X, Hovey RL, Huang CC, Wang L) Oncotarget 2015 Jun 30;6(18):16411-21 43 Citations |
| 1 | Prostate histoscanning true targeting guided prostate biopsy: initial clinical experience. (Sivaraman A, Sanchez-Salas R, Barret E, Macek P, Validire P, Galiano M, Rozet F, Cathelineau X) World J Urol 2015 Oct;33(10):1475-9 14 Citations |
| 3 | Assessment and management of interfractional variations in daily diagnostic-quality-CT guided prostate-bed irradiation after prostatectomy. (Liu F, Ahunbay E, Lawton C, Li XA) Med Phys 2014 Mar;41(3):031710 29 Citations |
| 1 | Periprostatic adipose tissue from obese prostate cancer patients promotes tumor and endothelial cell proliferation: a functional and MR imaging pilot study. (Venkatasubramanian PN, Brendler CB, Plunkett BA, Crawford SE, Fitchev PS, Morgan G, Cornwell ML, McGuire MS, Wyrwicz AM, Doll JA) Prostate 2014 Feb;74(3):326-35 38 Citations |
| 1 | High-resolution transrectal ultrasound: pilot study of a novel technique for imaging clinically localized prostate cancer. (Pavlovich CP, Cornish TC, Mullins JK, Fradin J, Mettee LZ, Connor JT, Reese AC, Askin FB, Luck R, Epstein JI, Burke HB) Urol Oncol 2014 Jan;32(1):34.e27-32 52 Citations |
| 1 | Visualizing the prostate gland by MR imaging in young and old mice. (Ravoori M, Duggal J, Gagea M, Han L, Singh S, Liu P, Wei W, Ragan DK, Bankson JA, Ma J, Kundra V) PLoS One 2013;8(3):e55746 5 Citations |
| 1 | Diffusion-weighted magnetic resonance imaging of the prostate: improved robustness with stretched exponential modeling. (Mazaheri Y, Afaq A, Rowe DB, Lu Y, Shukla-Dave A, Grover J) J Comput Assist Tomogr 2012;36(6):695-703 61 Citations |
| 1 | Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer. (Kim Y, Ignatchenko V, Yao CQ, Kalatskaya I, Nyalwidhe JO, Lance RS, Gramolini AO, Troyer DA, Stein LD, Boutros PC, Medin JA, Semmes OJ, Drake RR, Kislinger T) Mol Cell Proteomics 2012 Dec;11(12):1870-84 82 Citations |
| 2 | Accumulating daily-varied dose distributions of prostate radiation therapy with soft-tissue-based kV CT guidance. (Godley A, Ahunbay E, Peng C, Li XA) J Appl Clin Med Phys 2012 May 10;13(3):3859 19 Citations |
| 1 | Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas. (Gay HA, Barthold HJ, O'Meara E, Bosch WR, El Naqa I, Al-Lozi R, Rosenthal SA, Lawton C, Lee WR, Sandler H, Zietman A, Myerson R, Dawson LA, Willett C, Kachnic LA, Jhingran A, Portelance L, Ryu J, Small W Jr, Gaffney D, Viswanathan AN, Michalski JM) Int J Radiat Oncol Biol Phys 2012 Jul 01;83(3):e353-62 520 Citations |
| 1 | Identification of prostate-enriched proteins by in-depth proteomic analyses of expressed prostatic secretions in urine. (Principe S, Kim Y, Fontana S, Ignatchenko V, Nyalwidhe JO, Lance RS, Troyer DA, Alessandro R, Semmes OJ, Kislinger T, Drake RR, Medin JA) J Proteome Res 2012 Apr 06;11(4):2386-96 70 Citations |
| 3 | Specific heat capacity of freshly excised prostate specimens. (Patch SK, Rao N, Kelly H, Jacobsohn K, See WA) Physiol Meas 2011 Nov;32(11):N55-64 10 Citations |
| 1 | Anti-proliferative effect of a putative endocannabinoid, 2-arachidonylglyceryl ether in prostate carcinoma cells. (Nithipatikom K, Isbell MA, Endsley MP, Woodliff JE, Campbell WB) Prostaglandins Other Lipid Mediat 2011 Feb;94(1-2):34-43 43 Citations |
| 1 | Overexpression of transforming growth factor β1 in malignant prostate cells is partly caused by a runaway of TGF-β1 auto-induction mediated through a defective recruitment of protein phosphatase 2A by TGF-β type I receptor. (Yu N, Kozlowski JM, Park II, Chen L, Zhang Q, Xu D, Doll JA, Crawford SE, Brendler CB, Lee C) Urology 2010 Dec;76(6):1519.e8-13 29 Citations |
| 4 | Characterizing interfraction variations and their dosimetric effects in prostate cancer radiotherapy. (Peng C, Ahunbay E, Chen G, Anderson S, Lawton C, Li XA) Int J Radiat Oncol Biol Phys 2011 Mar 01;79(3):909-14 70 Citations |
| 1 | Thrombospondin-1 regulates the normal prostate in vivo through angiogenesis and TGF-beta activation. (Fitchev PP, Wcislak SM, Lee C, Bergh A, Brendler CB, Stellmach VM, Crawford SE, Mavroudis CD, Cornwell ML, Doll JA) Lab Invest 2010 Jul;90(7):1078-90 24 Citations |
| 3 | Online adaptive replanning method for prostate radiotherapy. (Ahunbay EE, Peng C, Holmes S, Godley A, Lawton C, Li XA) Int J Radiat Oncol Biol Phys 2010 Aug 01;77(5):1561-72 86 Citations |
| 1 | In-depth proteomic analyses of direct expressed prostatic secretions. (Drake RR, Elschenbroich S, Lopez-Perez O, Kim Y, Ignatchenko V, Ignatchenko A, Nyalwidhe JO, Basu G, Wilkins CE, Gjurich B, Lance RS, Semmes OJ, Medin JA, Kislinger T) J Proteome Res 2010 May 07;9(5):2109-16 66 Citations |
| 1 | Relaxin-3 and receptors in the human and rhesus brain and reproductive tissues. (Silvertown JD, Neschadim A, Liu HN, Shannon P, Walia JS, Kao JC, Robertson J, Summerlee AJ, Medin JA) Regul Pept 2010 Jan 08;159(1-3):44-53 24 Citations |
| 2 | Automated registration of large deformations for adaptive radiation therapy of prostate cancer. (Godley A, Ahunbay E, Peng C, Li XA) Med Phys 2009 Apr;36(4):1433-41 54 Citations |
| 1 | ACR appropriateness criteria on external beam radiation therapy treatment planning for clinically localized prostate cancer expert panel on radiation oncology--prostate. (Michalski JM, Roach M 3rd, Merrick G, Anscher MS, Beyer DC, Lawton CA, Lee WR, Pollack A, Rosenthal SA, Vijayakumar S, Carroll PR) Int J Radiat Oncol Biol Phys 2009 Jul 01;74(3):667-72 16 Citations |
| 1 | Recutting prostate needle core biopsies with high grade prostatic intraepithelial neoplasia increases detection of adenocarcinoma. (Rapp DE, Msezane LP, Reynolds WS, Lotan TL, Obara P, O'Connor RC, Taxy JB, Gerber GS, Zagaja GP) Can J Urol 2009 Feb;16(1):4484-9 6 Citations |
| 3 | A comparison of daily megavoltage CT and ultrasound image guided radiation therapy for prostate cancer. (Peng C, Kainz K, Lawton C, Li XA) Med Phys 2008 Dec;35(12):5619-28 25 Citations |
| 2 | SmgGDS is up-regulated in prostate carcinoma and promotes tumour phenotypes in prostate cancer cells. (Zhi H, Yang XJ, Kuhnmuench J, Berg T, Thill R, Yang H, See WA, Becker CG, Williams CL, Li R) J Pathol 2009 Feb;217(3):389-97 22 Citations |
| 1 | Fas-mediated killing of primary prostate cancer cells is increased by mitoxantrone and docetaxel. (Symes JC, Kurin M, Fleshner NE, Medin JA) Mol Cancer Ther 2008 Sep;7(9):3018-28 22 Citations |
| 4 | An on-line replanning scheme for interfractional variations. (Ahunbay EE, Peng C, Chen GP, Narayanan S, Yu C, Lawton C, Li XA) Med Phys 2008 Aug;35(8):3607-15 124 Citations |
| 1 | Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis. (Gurel B, Iwata T, Koh CM, Jenkins RB, Lan F, Van Dang C, Hicks JL, Morgan J, Cornish TC, Sutcliffe S, Isaacs WB, Luo J, De Marzo AM) Mod Pathol 2008 Sep;21(9):1156-67 375 Citations |
| 1 | In vivo MRI volumetric measurement of prostate regression and growth in mice. (Nastiuk KL, Liu H, Hamamura M, Muftuler LT, Nalcioglu O, Krolewski JJ) BMC Urol 2007 Jul 24;7:12 25 Citations |
| 2 | Elevated 12- and 20-hydroxyeicosatetraenoic acid in urine of patients with prostatic diseases. (Nithipatikom K, Isbell MA, See WA, Campbell WB) Cancer Lett 2006 Feb 28;233(2):219-25 44 Citations |
| 1 | Early release of the neurovascular bundles and optical loupe magnification lead to improved and earlier return of potency following radical retropubic prostatectomy. (Chuang MS, O'Connor RC, Laven BA, Orvieto MA, Brendler CB) J Urol 2005 Feb;173(2):537-9 31 Citations |
| 1 | Pigment epithelium-derived factor, a human testis epididymis secretory product, promotes human prostate stromal cell growth in culture. (Grayhack JT, Smith ND, Ilio K, Wambi C, Kasjanski R, Crawford SE, Doll JA, Wang Z, Lee C, Kozlowski JM) J Urol 2004 Jan;171(1):434-8 9 Citations |
| 1 | Dose escalation in permanent brachytherapy for prostate cancer: dosimetric and biological considerations. (Li XA, Wang JZ, Stewart RD, DiBiase SJ) Phys Med Biol 2003 Sep 07;48(17):2753-65 46 Citations |
| 1 | Urethral stents in benign prostate hyperplasia. (Donnell RF) Curr Urol Rep 2003 Aug;4(4):282-6 4 Citations |
| 1 | Variability of the International Prostate Symptom Score in men with lower urinary tract symptoms. (O'Connor RC, Bales GT, Avila D, Gerber GS) Scand J Urol Nephrol 2003;37(1):35-7 17 Citations |
| 1 | Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas. (Doll JA, Stellmach VM, Bouck NP, Bergh AR, Lee C, Abramson LP, Cornwell ML, Pins MR, Borensztajn J, Crawford SE) Nat Med 2003 Jun;9(6):774-80 278 Citations |
| 1 | Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate. (Doll JA, Reiher FK, Crawford SE, Pins MR, Campbell SC, Bouck NP) Prostate 2001 Dec 01;49(4):293-305 128 Citations |
| 1 | Monte Carlo dose verification for intensity-modulated arc therapy. (Li XA, Ma L, Naqvi S, Shih R, Yu C) Phys Med Biol 2001 Sep;46(9):2269-82 39 Citations |
| 1 | Binding and functional properties of endothelin receptor subtypes in the human prostate. (Kobayashi S, Tang R, Wang B, Opgenorth T, Langenstroer P, Shapiro E, Lepor H) Mol Pharmacol 1994 Feb;45(2):306-11 67 Citations |
| 1 | Endothelin-1 in the human prostate: tissue levels, source of production and isometric tension studies. (Langenstroer P, Tang R, Shapiro E, Divish B, Opgenorth T, Lepor H) J Urol 1993 Aug;150(2 Pt 1):495-9 116 Citations |
| 1 | Sonographic diagnosis of enlarged prostatic utricle. (Gregg DC, Sty JR) J Ultrasound Med 1989 Jan;8(1):51-2 9 Citations |
| 1 | Antigenicity and autoimmunity in sexual reproduction: a review. (Shulman S) Clin Exp Immunol 1971 Sep;9(3):267-88 48 Citations |
